February 15, 2012 News release
news
Forest Laboratories and Gedeon Richter have announced preliminary top-line results from a Phase III clinical trial of Cariprazine (RGH-188), an investigational antipsychotic agent, in patients with acute mania associated with bipolar I disorder.
February 7, 2012 Nick Zubko, Associate Editor
blog
Could there be a way to diagnose depression from a simple blood test? Based on a new study conducted by researchers at Massachusetts General Hospital in Boston, the possibility may be closer to reality than you think.
February 3, 2012 H. Steven Moffic, MD
blog
As some Americans recognize February as "National African American History Month," too few of them, even in the field of behavioral health, pause to recognize the continued patterns of prejudice in diagnosis and treatment that make African American males far more likely to be diagnosed with serious mental illness or incarcerated for drug-possession offenses. It's time we took a look at that problem.
February 2, 2012 Dennis Grantham, Editor-in-Chief
blog
For years, mental health providers have worried about the incidence of "metabolic syndrome" among consumers taking atypical antipsychotic meds for serious mental illness. Now, a study has identified the link.
February 1, 2012 News release
news
Researchers at Sanford-Burnham Medical Research Institute have released a paper describing how antipsychotic drugs interfere with normal metabolism by activating a protein called SMAD3, an important part of the transforming growth factor beta (TGFβ) pathway.
